DiamiR Receives Patent Allowance for Rett MicroRNA Biomarker

DiamiR Receives Patent Allowance for Rett MicroRNA Biomarker

287227

DiamiR Receives Patent Allowance for Rett MicroRNA Biomarker

The United States Patent and Trademark Office (USPTO) has issued an allowance for a patent submitted by DiamiR for methods the company developed that use microRNA (miRNA) as biomarkers of Rett syndrome and other neurodevelopmental diseases.  Notices of Allowance are issued by the USPTO when it believes that an invention qualifies for a patent. DamiR’s approaches are based on targeted analysis of miRNAs that have been found to be highly produced in the brain and…

You must be logged in to read/download the full post.